FindTrial
Sign In

Evaluation of the clinical utility of rTMS in acute stroke, and identification of individualized resting EEG predictors of outcome

Evaluation of the clinical utility of rTMS in acute stroke, and identification of individualized resting EEG predictors of outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021255
Enrollment
Unknown
Registered
2019-02-03
Start date
2019-02-27
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Pseudo stimulation grou:Pseudo rTMS
True stimulation group:True rTMS

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female; 2. Aged 18-75 years old; 3. Definite diagnosis of cerebral infarction; 4. Within 10 days of onset; 5. The affected side muscle strength is 2-4.

Exclusion criteria

Exclusion criteria: 1. Cerebral hemorrhage; 2. Brain tumor; 3. History of traumatic brain injury; 4. History of epilepsy; 5. Implantation of various metal objects in the body; 6. Drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer;NIHSS;HAMA;HAMD;MMSE;—

Countries

China

Contacts

Public ContactHuang Ying

Department of Neurogy Shenzhen People's Hospital

627501849@qq.com+86 15919822508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026